Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$218.29 - $256.91 $178,124 - $209,638
816 New
816 $207,000
Q2 2022

Aug 15, 2022

BUY
$234.74 - $275.42 $938 - $1,101
4 Added 0.49%
819 $202,000
Q1 2022

May 16, 2022

BUY
$243.64 - $270.48 $487 - $540
2 Added 0.25%
815 $202,000
Q4 2021

Feb 14, 2022

BUY
$230.08 - $250.94 $187,055 - $204,014
813 New
813 $204,000
Q3 2021

Nov 16, 2021

SELL
$232.72 - $256.47 $188,735 - $207,997
-811 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$232.65 - $254.58 $188,679 - $206,464
811 New
811 $200,000
Q1 2021

May 17, 2021

SELL
$232.09 - $256.88 $190,777 - $211,155
-822 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$221.92 - $245.94 $182,418 - $202,162
822 New
822 $206,000
Q3 2020

Nov 16, 2020

SELL
$215.77 - $276.76 $175,852 - $225,559
-815 Closed
0 $0
Q2 2020

Aug 13, 2020

BUY
$219.9 - $263.41 $179,218 - $214,679
815 New
815 $210,000
Q1 2020

May 15, 2020

SELL
$195.69 - $279.01 $157,334 - $224,324
-804 Closed
0 $0
Q4 2019

Feb 11, 2020

SELL
$236.45 - $266.82 $7,566 - $8,538
-32 Reduced 3.83%
804 $219,000
Q3 2019

Nov 14, 2019

BUY
$230.58 - $256.08 $192,764 - $214,082
836 New
836 $211,000

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $65.1B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Vivaldi Capital Management LP Portfolio

Follow Vivaldi Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vivaldi Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Vivaldi Capital Management LP with notifications on news.